用相对时间的概念,用两个不同的韦布尔分布来进行对事件的时间对事件结果的组序列设计,并使用非成比例的危险
Milind A Phadnis1, Nadeesha Thewarapperuma1, Matthew S Mayo1
1Department of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, KS, USA.
Contemporary clinical trials communications
|July 22, 2024
概括
本研究引入了一个新的组序列设计,用于第三阶段临床试验,在不适用比例危险的情况下使用生存终点. 基于模拟的方法为时间到事件数据分析提供了灵活性.
科学领域:
- 生物统计学 生物统计学
- 临床试验设计 临床试验设计
- 生存分析的分析.
背景情况:
- 组序列设计允许在III期试验中临时监测疗效和安全性.
- 现有的时间到事件结果的方法通常依赖于比例危险假设,这可能是限制性的.
- 不成比例的危害场景需要替代方法来进行稳健的临床试验设计.
研究的目的:
- 提出一种基于模拟的新型组序列设计,用于具有生存终点的双臂随机III期临床试验.
- 应对比例危险假设不适当的场景.
- 为分析时间到事件数据提供灵活和实用的设计.
主要方法:
- 基于模拟的组序列设计是为时间到事件结果开发的.
- 该方法假设生存时间遵循两个不同的韦布尔分布.
- 相对时间用于计算中间分析中的疗效和安全边界.
- 一个非对称的正常测试统计允许在每个边界计算p值.
主要成果:
- 拟议的设计适应了生存终点试验中不成比例的危险.
- 它提供了灵活性,将加速失效时间和比例危险模型作为特殊情况纳入.
- 该方法允许结合各种时间到事件数据特征.
- 由于异常正常的测试统计数据,可以在每个中间边界计算p值.
结论:
- 基于模拟的新型组序列设计为第三阶段试验提供了切实可行的解决方案,在不成比例的危险下具有生存终点.
- 这种方法提高了临床试验分析中临时监测的灵活性和适用性.
- 该方法通过现实生活中的应用证明了实用性,为生物统计学家和临床研究人员提供了有价值的工具.
相关概念视频
01:14Parametric Survival Analysis: Weibull and Exponential Methods
395
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
395
01:20Comparing the Survival Analysis of Two or More Groups
170
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
170
01:18Introduction To Survival Analysis
203
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
203
01:15Assumptions of Survival Analysis
119
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
119
01:11Hazard Rate
99
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
99
01:24Kaplan-Meier Approach
119
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
119